Surprisingly, although i(17q) appeared in 6/150 (4%) here studied CLL patients, that is, and 6/18 (~33%) of CLL patients with a deletion of TP53, this chromosomal aberration has not been studied in detail yet in this patient group. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.